-
March 19, 2024 Lupin Receives Approval from U.S. FDA for Aripiprazole Tablets, USP
-
March 18, 2024 Lupin Appoints Christoph Funke as Chief Technical Operations Officer
-
March 15, 2024 Lupin Receives Approval from U.S. FDA for Doxycycline for Injection USP
-
March 11, 2024 Lupin and Birmingham City University Honour Graduates of Master’s Programme in Advancing Diabetes Care
-
March 8, 2024 Lupin Appoints Rakesh Bhardwaj as Chief Information Officer
-
February 23, 2024 Lupin Enters the S&P Global Sustainability Yearbook 2024
-
February 16, 2024 Lupin Receives Approval from U.S. FDA for Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate Tablets)
-
February 16, 2024 EffRx Pharmaceuticals Signs Exclusive Licensing and Distribution Agreement with Lupin for Commercialization of BINOSTO® in Vietnam & Philippines
-
February 15, 2024 Lupin Launches Ganirelix Acetate Injection in the United States
In this section
Media Contacts
-
Shweta Munjal
Vice President & Global Head – Corporate Communications and Sustainability